KalVista Pharmaceuticals, Inc. (KALV) › Shares OutstandingKalVista Pharmaceuticals, Inc. (KALV) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 691.3K2015: 26.32M2016: 02017: 9.71M2018: 10.80M2019: 17.28M2020: 17.85M2021: 24.42M2022: 24.55M2023: 34.17M2024: 42.52M2025: 50.90M50.90M2014Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202550.90M+19.7%202442.52M+24.4%202334.17M+39.2%202224.55M+0.5%202124.42M+36.9%202017.85M+3.3%201917.28M+60.0%201810.80M+11.2%20179.71M—20160-100.0%201526.32M+3707.6%2014691.3K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share